Target intelligence / Profile preview

Reactive oxygen species and protein disulfides (ROS/Protein disulfides)

Target
ROS/Protein disulfides
Molecular classification
Other, Reactive molecules, Post-translational modifications
01

Overview

Reactive oxygen species (ROS) and protein disulfides are central components of cellular redox biology, acting as both signaling molecules and mediators of oxidative damage. ROS, such as superoxide and hydrogen peroxide, are produced during mitochondrial respiration and by enzymes like NADPH oxidases; they regulate various pathways including cell proliferation and immune responses (PMID: 21233337). Protein disulfides are formed through the oxidation of cysteine residues, a process often facilitated by ROS or enzymes like protein disulfide-isomerase (PDI), and are essential for proper protein folding and structural stability (PMID: 15103334). However, an imbalance between ROS production and antioxidant defenses leads to oxidative stress, resulting in aberrant protein disulfide formation and cellular dysfunction associated with cancer, neurodegeneration, and cardiovascular disease (PMID: 25236395, PMID: 16430502). Therapeutic interventions include ROS scavengers like N-acetylcysteine and edaravone, as well as inhibitors of redox-active enzymes, aimed at restoring homeostasis or selectively inducing oxidative stress in tumor cells (DrugBank DB01151, PMID: 28249518).

Other names
Oxidative stress mediatorsRedox signaling moleculesProtein thiol-disulfide exchange systemReactive oxygen speciesProtein disulfides
02

Mechanism of action

Direct scavenging of reactive oxygen species, inhibition of ROS-producing enzymes (e.g., NADPH oxidase), or modulation of enzymes involved in thiol-disulfide exchange such as protein disulfide-isomerase (PDI) and thioredoxin (PMID: 28249518, DrugBank DB01151).

03

Biological functions

Signal transductionProtein foldingApoptosisRedox homeostasisImmune response
04

Disease associations

CancerNeurodegenerative diseaseCardiovascular diseaseInflammationDiabetes
05

Safety considerations

Interference with physiological redox signalingPotential pro-oxidant effects at high dosesLack of cellular specificityAntioxidant paradox (potential for increased mortality in some clinical trials)
06

Interacting drugs

N-acetylcysteine

7 more in the full profile.

07

Biomarkers

8-hydroxy-2'-deoxyguanosine (8-OHdG)Malondialdehyde (MDA)Glutathione/GSSG ratioProtein carbonyls8-isoprostane

Beyond the preview

Go deeper on Reactive oxygen species and protein disulfides (ROS/Protein disulfides).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reactive oxygen species and protein disulfides (ROS/Protein disulfides).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call